On 4 JUNE 21Vianet Group Inc (NASDAQ:VNET) announced that the Company and its affiliate have entered into definitive agreements to invest in Sichuan Aipu Network Co., Ltd. and its affiliates (collectively, the “Aipu Group”). 21Vianet Group Inc (NASDAQ:VNET) net profit margin is -2.50% and weekly performance is 1.74%. On last trading day company shares ended up $27.43. Analysts mean target price for the company is $32.33. 21Vianet Group Inc (NASDAQ:VNET) distance from 50-day simple moving average (SMA50) is 6.94%.
On 30 MAY Tarena International Inc (ADR) (NASDAQ:TEDU) announced that it has signed a cooperation agreement with Taiyuan Institute of Technology (“TIT”), a state-owned undergraduate college in Taiyuan, China. Established since 1954, TIT currently has over 14,000 full-time students. Tarena International Inc (ADR) (NASDAQ:TEDU) shares advanced 8.55% in last trading session and ended the day on $9.90. TEDU Gross Margin is 68.60% and its return on assets is -60.30%.
On 5 JUNE Comtech Telecommunications Corp. (NASDAQ:CMTL) reported its operating results for the three and nine months ended April 30, 2014. Net sales for the third quarter of fiscal 2014 were $88.9 million compared to $69.9 million for the third quarter of fiscal 2013. The period-over-period increase reflects higher sales in the Company’s telecommunications transmission and RF microwave amplifiers segments, partially offset by lower sales in its mobile data communications segment. Comtech Telecomm. Corp. (NASDAQ:CMTL) shares moved up 17.49% in last trading session and was closed at $38.76, while trading in range of $34.20 – $38.90. Comtech Telecomm. Corp. (NASDAQ:CMTL) year to date (YTD) performance is 25.36%.
On 19 MAY Mechel OAO (ADR) (NYSE:MTL) announces the appointment of Andrey Slivchenko as the new Chief Financial Officer of Mechel OAO, replacing Stanislav Ploschenko. Mechel OAO (ADR) (NYSE:MTL) ended the last trading day at $2.00. Company weekly volatility is calculated as 5.14% and price to cash ratio as 2.58. Mechel OAO (ADR) (NYSE:MTL) showed a positive weekly performance of 3.63%.
On 10 MAY Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) updated its drug development progress and reported financial results for the three months ended March 31, 2014. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) ‘s revenues for the three months ended March 31, 2014 decreased 23 percent to $0.3 million from $0.4 million for the corresponding period in 2013, primarily due to lower revenues from Lexicon’s alliance with Taconic Farms. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) weekly performance is 10.61%. On last trading day company shares ended up $1.46. Analysts mean target price for the company is $2.70. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) distance from 50-day simple moving average (SMA50) is -2.96%.